Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial

Overview of attention for article published in JACC, July 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 3 news outlets

twitter: 90 X users

Citations

dimensions_citation: 101 Dimensions

Readers on

mendeley: 129 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Analyses identify candidates for rivaroxaban-aspirin therapy

Medical Health News, 08 Jul 2019

Sonya S. Anand Two new analyses based on the COMPASS trial identified patients at high vascular risk and with enrichment…

Analyses identify candidates for rivaroxaban-aspirin therapy

Healio.com, 08 Jul 2019

Sonya S. Anand Two new analyses based on the COMPASS trial identified patients at high vascular risk and with enrichment…

Rivaroxaban + aspirina in prevenzione secondaria, beneficio netto maggiore nei pazienti a rischio pi alto

Pharmastar Italy, 30 Jun 2019

Dare ai pazienti una combinazione di rivaroxaban a basso dosaggio e di una terapia con aspirina (ASA) per la prevenzione…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.